Sensei Biotherapeutics, Inc.
SNSE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $11,919 | $10,818 | $198,516 | $246,617 |
| - Cash | $10,562 | $12,557 | $9,877 | $9,994 |
| + Debt | $2,021 | $2,559 | $3,208 | $3,845 |
| Enterprise Value | $3,378 | $820 | $191,847 | $240,468 |
| Revenue | -$4,851 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$37 | -$30 | -$139 |
| % Margin | -0% | – | – | – |
| EBITDA | -$4,529 | -$4,889 | -$6,821 | -$7,614 |
| % Margin | 93.4% | – | – | – |
| Net Income | -$4,569 | -$4,936 | -$6,864 | -$7,770 |
| % Margin | 94.2% | – | – | – |
| EPS Diluted | -3.62 | -3.91 | -0.27 | -0.31 |
| % Growth | 7.4% | -1,348.1% | 12.9% | – |
| Operating Cash Flow | -$3,586 | -$5,909 | -$7,094 | -$5,792 |
| Capital Expenditures | $0 | -$16 | $0 | $0 |
| Free Cash Flow | -$3,586 | -$5,925 | -$7,094 | -$5,792 |